Literature DB >> 5725281

Toxic effects of glucagon-induced acute lipid mobilization in geese.

J C Hoak, W E Connor, E D Warner.   

Abstract

The toxic effects associated with rapid lipid mobilization and a high plasma free fatty acid (FFA) concentration produced by glucagon were evaluated. Glucagon (0.5 mg/kg of body wt) was injected intravenously into nonfasting geese. The geese developed rapid respirations and high plasma FFA levels within 15 min after the glucagon injection; three of eleven died. Control geese, injected with saline, did not exhibit toxic signs. Peak FFA concentrations developed 15 min after glucagon and high levels persisted for over 90 min. Geese injected with glucagon frequently developed electrocardiographic abnormalities that included supraventricular tachycardia, premature ventricular contractions, and signs of myocardial ischemia. Light and electron microscopy revealed acute myocardial degeneration and fatty infiltration of the liver. The increase in plasma FFA concentrations and toxic effects were not prevented by pretreatment with nicotinic acid or propranolol.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5725281      PMCID: PMC297441          DOI: 10.1172/JCI105953

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  EFFECT OF AVIAN PITUITARY PREPARATIONS ON THE PLASMA FREE FATTY ACIDS OF THE RABBIT AND THE DOMESTIC FOWL.

Authors:  P J HEALD; K A ROOKLEDGE
Journal:  Nature       Date:  1964-04-25       Impact factor: 49.962

2.  UNRESPONSIVENESS TO THE LIPID MOBILIZING ACTION OF CATECHOLAMINES IN VIVO AND VITRO IN THE DOMESTIC FOWL.

Authors:  L A CARLSON; S O LILJEDAHL; M VERDY; C WIRSEN
Journal:  Metabolism       Date:  1964-03       Impact factor: 8.694

3.  BIOCHEMICAL LESION OF DIPHTHERIA TOXIN IN THE HEART.

Authors:  B WITTELS; R BRESSLER
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

4.  THROMBOSIS ASSOCIATED WITH MOBILIZATION OF FATTY ACIDS.

Authors:  J C HOAK; J C POOLE; D S ROBINSON
Journal:  Am J Pathol       Date:  1963-12       Impact factor: 4.307

5.  ALBUMIN ANTAGONISM OF FATTY ACID EFFECTS ON OXIDATION AND PHOSPHORYLATION REACTIONS IN RAT LIVER MITOCHONDRIA.

Authors:  P BJOERNTORP; H A ELLS; R H BRADFORD
Journal:  J Biol Chem       Date:  1964-01       Impact factor: 5.157

6.  Pathologic changes induced by 1-norepineprine: quantitative aspects.

Authors:  J E SZAKACS; B MEHLMAN
Journal:  Am J Cardiol       Date:  1960-05       Impact factor: 2.778

7.  Distribution of C14 in rats after intravenous injection of non-esterified palmitic acid-1-C14.

Authors:  S LAURELL
Journal:  Acta Physiol Scand       Date:  1959-06-24

8.  Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction.

Authors:  M F Oliver; V A Kurien; T W Greenwood
Journal:  Lancet       Date:  1968-04-06       Impact factor: 79.321

9.  [Glucagon and blood levels of non-esterified fatty acids in males].

Authors:  P Lefebvre
Journal:  Ann Endocrinol (Paris)       Date:  1965 Sep-Oct       Impact factor: 2.478

10.  Cardiovascular effects of sustained norepinephrine infusions. II. Morphology.

Authors:  E A Schenk; A J Moss
Journal:  Circ Res       Date:  1966-05       Impact factor: 17.367

View more
  4 in total

1.  [Biochemical and haemodynamic effects of zinc-protamin-glucagon in man (author's transl)].

Authors:  P Kühn; P Holzhey; M Niederberger; H Fritzsche; A Kroiss; B Brenner; F Kaindl
Journal:  Klin Wochenschr       Date:  1973-10-01

2.  [Lipid infiltration in experimental cardiac necrosis].

Authors:  C Gardell; K Kovács
Journal:  Can Vet J       Date:  1969-11       Impact factor: 1.008

3.  Effects of free fatty acids on electrophysiological properties of ventricular myocardium.

Authors:  B Lüderitz; C Naumann d'Alnocourt; G Steinbeck
Journal:  Klin Wochenschr       Date:  1976-04-01

4.  Haemodynamic effects of glucagon.

Authors:  J G Murtagh; P F Binnion; S Lal; K J Hutchison; E Fletcher
Journal:  Br Heart J       Date:  1970-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.